$obmp

OncBioMune Pharmaceuticals, Inc.

http://oncbiomune.com/

Symbol: OBMP

Top 10 Reasons to Buy OBMP

1. Consolidation over the past week looks to be over, next move up on the charts starting. Full size chart

 

$obmp12

 

2. Lead product is ProscaVax that is in the planning stage of a Phase II clinical trial for the treatment of prostate cancer

3. A clinical stage biopharmaceutical company that develops cancer immunotherapy products

4. Announces Cancer Vaccine Poster Presentation at the 2017 American Association for Cancer Research Meeting

5. 9 of the 14 patients that have received 6 vaccines have had increased PSA doubling time, suggesting ProscaVax is slowing tumor growth.

6. Preparing to enter a Phase 2/3 trial in Mexico through a Joint Venture with its acquisition target and Mexican partner Vital Laboratorios S.A. de C.V

7. Departments of Urology and Oncology Approve Protocol for OncBioMune’s Phase 2/3 Trial of ProscaVax for Prostate Cancer in Mexico

8. Awarded Patent in Europe Protecting Novel Cancer Vaccine Technology

9. Shares Outstanding 61,158,013 a/o Feb 24, 2017; Float 11,861,349 a/o Feb 24,2017

10. OTC QB SEC Reporting Current

http://oncbiomune.com/

Brought to you by: Blue Horseshoe Alerts
www.bluehorseshoealerts.com
Sign up for our free newsletter

 

 

 

 

Leave a Reply

Your email address will not be published.Required fields are marked *